Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.
about
Modes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological ImplicationsControl of CD8 T-Cell Infiltration into Tumors by Vasculature and MicroenvironmentNew perspectives on the role of vitiligo in immune responses to melanomaTCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicityImmune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinityPeripheral tissue homing receptor control of naïve, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues.CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1.Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouseInterferon-γ induces senescence in normal human melanocytes.Association of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo PathogenesisTumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.HSP70i is a critical component of the immune response leading to vitiligoAutoimmune vitiligo in rheumatic disease in the mestizo Mexican population.Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligoMutant HSP70 reverses autoimmune depigmentation in vitiligo.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.A quantitative increase in regulatory T cells controls development of vitiligo.Innate immune mechanisms in vitiligo: danger from within.Understanding mechanisms of autoimmunity through translational research in vitiligo.Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and lossIncreased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.Nonsegmental vitiligo and autoimmune mechanism.Melanocyte Regeneration in Vitiligo Requires WNT beneath their Wings.A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.MicroRNA expression profiling identifies potential serum biomarkers for non-segmental vitiligo.A mouse model of vitiligo induced by monobenzone.Antroquinonol Exerts Immunosuppressive Effect on CD8+ T Cell Proliferation and Activation to Resist Depigmentation Induced by H2O2.Vitiligo
P2860
Q26781338-B3E357E5-312F-48EA-9294-BF95EA2421B6Q26799117-55B43309-375D-4078-8BE1-16EDDBC02542Q26996799-FACF9449-9603-45A7-BC30-1FFBC379B728Q28081699-ABC8FE72-7DD5-4E60-B3C9-3484F6F3DE1DQ30371711-557C4B0C-7564-41D3-A83A-F03D0333FFC1Q30413827-C5FC7932-2B66-4E4B-85D3-258971D7EC00Q30417609-F86B977A-07F6-4D4B-93C9-F873E012999FQ33864128-B71950FA-17AC-4E03-A410-FCD0F746F10FQ33985283-885D22FA-C28F-4261-AD38-C9E3C06956EEQ34692289-6B29570F-3DF1-4C92-AC51-CB9FB2482BE7Q35107211-3729449E-239F-45FD-812E-2EA5A4EE42C2Q35134926-79FE2F9F-E5C7-4143-B365-2A653EB2FB4DQ36084225-3486AE39-0E28-4A95-A3FB-DBE838FF4889Q36094915-65F1D888-BA1E-4C20-A7E6-046EFDD9C70AQ36871508-76DC068E-1AFC-44BF-884A-757E1664D0DFQ37108013-882C74AA-6A49-44E9-A4F0-74EF4E52A912Q37240967-8D1E2A22-0A29-4F63-A473-7E540B0E48CDQ37271641-906A4F28-E21A-442E-9017-662A3D583588Q37551330-34D660E7-6C3D-4DC1-9576-EF07CA59BEEFQ37611016-72741E92-D822-4B9B-B917-486BF1129A3BQ37707149-B7A38E2D-4A8C-4E38-967B-A3BB64CD0A60Q38163168-BBCC1E00-9F9A-4464-B0C0-1291BCD5643FQ38808662-26D7848D-D921-4D23-9684-DCC1D61B972FQ38943432-5BF01EB4-3D38-45DF-BE90-14DEE47235EEQ39412203-EC1AD825-74AB-4F2B-B865-2636096884DFQ39419931-29F936F9-251A-40DF-AE47-2023DC8270B2Q39976037-88D34F50-D7B4-43A1-B0D2-D46941DFD56AQ40072169-B8631320-E8D1-48CE-B705-61144D2C1507Q41783600-CE70AC7A-61BE-4BF3-8B32-BC0090C3B455Q41954249-E219C81E-D7E2-43F8-BC38-319BAC494A42Q42128877-3CE50760-72C9-4DF8-83E5-200A81D4BB4EQ42145851-4B3DA4AD-9ECC-4A79-82AC-5B2334714411Q43941329-AD94D6C0-502A-431A-A0C7-80B5F7EE6BF1Q45920052-70003EA8-988A-4C73-BA30-7CD7DCDA5EACQ49874456-F5718916-A79C-46BD-912B-9ADAD6C32B8DQ56996499-3C197AF1-B4B8-45A8-8ABB-890CBC721792
P2860
Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@ast
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@en
type
label
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@ast
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@en
prefLabel
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@ast
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@en
P2093
P2860
P356
P1476
Mechanisms of spatial and temp ...... -specific TCR transgenic mice.
@en
P2093
Lisa Nichols
Randal K Gregg
Yiming Chen
P2860
P304
P356
10.4049/JIMMUNOL.0902778
P407
P577
2010-01-18T00:00:00Z